Halozyme Therapeutics (HALO) Interest Coverage Ratio (2016 - 2025)
Halozyme Therapeutics (HALO) has disclosed Interest Coverage Ratio for 13 consecutive years, with 18.91 as the latest value for Q4 2025.
- On a quarterly basis, Interest Coverage Ratio fell 148.93% to 18.91 in Q4 2025 year-over-year; TTM through Dec 2025 was 25.87, a 15.1% decrease, with the full-year FY2025 number at 25.87, down 15.1% from a year prior.
- Interest Coverage Ratio was 18.91 for Q4 2025 at Halozyme Therapeutics, down from 50.73 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 53.11 in Q2 2021 to a low of 18.91 in Q4 2025.
- A 5-year average of 26.69 and a median of 25.87 in 2021 define the central range for Interest Coverage Ratio.
- Peak YoY movement for Interest Coverage Ratio: soared 4384.26% in 2021, then crashed 148.93% in 2025.
- Halozyme Therapeutics' Interest Coverage Ratio stood at 27.51 in 2021, then tumbled by 40.74% to 16.3 in 2022, then rose by 18.72% to 19.36 in 2023, then soared by 99.72% to 38.66 in 2024, then plummeted by 148.93% to 18.91 in 2025.
- Per Business Quant, the three most recent readings for HALO's Interest Coverage Ratio are 18.91 (Q4 2025), 50.73 (Q3 2025), and 46.07 (Q2 2025).